Rigel Pharmaceuticals saw the highest growth of 0.24% in patent filings in April and 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.24% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Rigel Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Rigel Pharmaceuticals has been focused on protecting inventions in Israel(IL) with two publications in Q2 2024
The Israel(IL) Patent Office dominates the patent grants with nearly 33% of grants. The Japan(JP), Australia(AU), Israel(IL), and United States(US) patent Office are among the top ten patent offices where Rigel Pharmaceuticals is filings its patents. Among the top granted patent authorities, Rigel Pharmaceuticals has 33% of its grants in Israel(IL), 33% in United States(US) and 17% in Japan(JP).
Roche could be the strongest competitor for Rigel Pharmaceuticals
Patents related to rare diseases and climate change lead Rigel Pharmaceuticals's portfolio
Rigel Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change and Covid-19. For rare diseases, nearly 100% of patents were filed and 75% of patents were granted in Q2 2024.
Rheumatoid arthritis related patents lead Rigel Pharmaceuticals portfolio followed by atopic dermatitis (atopic eczema), and psoriasis
Rigel Pharmaceuticals has highest number of patents in rheumatoid arthritis followed by atopic dermatitis (atopic eczema), psoriasis, sarcomas, and adenocarcinoma. For rheumatoid arthritis, nearly 33% of patents were filed and 1% of patents were granted in Q2 2024.
For comprehensive analysis of Rigel Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
